Creso Pharma Ltd subsidiary Mernova's THC content testing on new cannabis strains exceeds industry average
This is a major achievement as it exceeds industry average and is another key competitive advantage, underpinning Mernova’s potential expansion into...
Source: proactiveinvestors.com